Pharmacists in Greenville, DE Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Dr. Stephanie M Wasserman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4011 Kennett Pike, Greenville, DE 19807 Phone: 024-275-6503 |
Mrs. Mary Elizabeth Nasr, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4011 Kennett Pike, Greenville, DE 19807 Phone: 302-427-5653 Fax: 302-427-5654 |
 Dr. Antonino Mazzamuto, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4011 Kennett Pike, Greenville, DE 19807 Phone: 302-427-5653 Fax: 302-427-5654 |
News Archive
Haemonetics announces reagent agreement with Quotient Biodiagnostics and Alba Bioscience
Haemonetics Corporation, a global blood management solutions company, today announced that it has entered into a reagent development and supply agreement with Quotient Biodiagnostics Group and its wholly owned subsidiary Alba Bioscience Limited. This arrangement provides Haemonetics with exclusive access to Alba's comprehensive catalogue of approved reagents for use in connection with the commercialization of its Arryx laser based blood typing platform.
Setting clocks ahead 1 hour may accelerate cardiac events in some, shows study
Still feeling the residual effects of springing ahead for daylight saving time? The hour of sleep lost - or gained - may play a bigger, perhaps more dangerous role in our body's natural rhythm than we think. It seems moving the clock forward or backward may alter the timing of when heart attacks occur in the week following these time changes, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.
Cholera can be controlled with oral vaccines
Endemic cholera, a potentially fatal diarrheal disease found in the world's most impoverished countries, could be effectively controlled by orally vaccinating half of the affected populations once every two years for only pennies per dose, according to new findings by an international team of researchers led by Ira M. Longini Jr., Ph.D., a biostatistician in the Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center in Seattle. Longini and colleagues will report their findings online Nov. 27 in PLoS Medicine.
BioAlliance Pharma to extend Validive phase II trial in head and neck cancer
BioAlliance Pharma SA, an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the extension of its phase II clinical trial with Validive in the United States in radio/chemotherapy-induced oral mucositis prevention in patients with head and neck cancer.
› Verified 6 days ago